News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
215,208 Results
Type
Article (12028)
Company Profile (111)
Press Release (203069)
Section
Business (59838)
Career Advice (415)
Deals (9291)
Drug Delivery (21)
Drug Development (30845)
Employer Resources (43)
FDA (3749)
Job Trends (4883)
News (102046)
Policy (8166)
Tag
2024 BioCapital Digital (6)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (7)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
Academia (977)
Adcomms (5)
Allergies (25)
Alliances (16818)
ALS (30)
Alzheimer's disease (482)
Antibody-drug conjugate (ADC) (29)
Approvals (3760)
Artificial intelligence (77)
Autoimmune disease (6)
Automation (4)
Bankruptcy (70)
Best Places to Work (4185)
BIOSECURE Act (13)
Biosimilars (16)
Biotechnology (93)
Bladder cancer (24)
Brain cancer (9)
Breast cancer (75)
Cancer (723)
Cardiovascular disease (19)
Career advice (379)
Career pathing (6)
CAR-T (71)
Cell therapy (219)
Cervical cancer (7)
Clinical research (23427)
Collaboration (323)
Compensation (111)
Complete response letters (5)
COVID-19 (2199)
CRISPR (22)
C-suite (109)
Cystic fibrosis (44)
Data (785)
Depression (10)
Diabetes (65)
Diagnostics (1826)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (14)
Drug discovery (54)
Drug pricing (11)
Drug shortages (3)
Duchenne muscular dystrophy (31)
Earnings (19168)
Editorial (8)
Employer branding (4)
Employer resources (38)
Events (45231)
Executive appointments (282)
FDA (4091)
Featured Employer (17)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (267)
Gene editing (48)
Generative AI (7)
Gene therapy (158)
GLP-1 (179)
Government (1609)
Guidances (14)
Healthcare (5334)
Huntington's disease (9)
IgA nephropathy (8)
Immunology and inflammation (32)
Indications (11)
Infectious disease (2305)
Inflammatory bowel disease (60)
Inflation Reduction Act (1)
Influenza (45)
Intellectual property (38)
Interviews (54)
IPO (4681)
IRA (6)
Job creations (906)
Job search strategy (340)
Kidney cancer (1)
Labor market (12)
Layoffs (79)
Legal (1338)
Liver cancer (24)
Lung cancer (66)
Lymphoma (63)
Management (12)
Manufacturing (100)
MASH (19)
Medical device (2261)
Medtech (2261)
Mergers & acquisitions (4834)
Metabolic disorders (162)
Multiple sclerosis (33)
NASH (1)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (637)
NextGen: Class of 2025 (1606)
Non-profit (1224)
Northern California (1019)
Now hiring (9)
Obesity (81)
Opinion (62)
Ovarian cancer (33)
Pain (27)
Pancreatic cancer (40)
Parkinson's disease (42)
Partnered (6)
Patents (76)
Patient recruitment (35)
Peanut (18)
People (20961)
Pharmaceutical (20)
Phase I (8652)
Phase II (10983)
Phase III (6683)
Pipeline (421)
Podcasts (4)
Policy (27)
Postmarket research (575)
Preclinical (4033)
Press Release (54)
Prostate cancer (28)
Psychedelics (5)
Radiopharmaceuticals (61)
Rare diseases (102)
Real estate (1887)
Recruiting (20)
Regulatory (5833)
Reports (15)
Research institute (828)
Resumes & cover letters (42)
Rett syndrome (1)
RNA editing (1)
RSV (44)
Schizophrenia (15)
Series A (46)
Series B (36)
Service/supplier (4)
Sickle cell disease (13)
Southern California (902)
Special edition (1)
Spinal muscular atrophy (52)
Sponsored (10)
Startups (1294)
State (1)
Stomach cancer (2)
Supply chain (16)
The Weekly (3)
United States (8170)
Vaccines (480)
Venture capitalists (7)
Webinars (9)
Weight loss (36)
Women's health (4)
Worklife (4)
Date
Today (58)
Last 7 days (267)
Last 30 days (1059)
Last 365 days (13132)
2025 (3025)
2024 (13574)
2023 (15078)
2022 (21221)
2021 (26949)
2020 (24460)
2019 (11269)
2018 (8686)
2017 (8750)
2016 (8375)
2015 (9434)
2014 (7256)
2013 (5915)
2012 (6449)
2011 (7131)
2010 (6527)
Location
Africa (303)
Alabama (30)
Alaska (1)
Arizona (42)
Arkansas (7)
Asia (12567)
Australia (2789)
California (2286)
Canada (708)
China (126)
Colorado (57)
Connecticut (96)
Delaware (44)
Europe (28941)
Florida (281)
Georgia (37)
Idaho (21)
Illinois (167)
India (5)
Indiana (117)
Iowa (2)
Japan (43)
Kansas (19)
Kentucky (5)
Louisiana (2)
Maine (8)
Maryland (330)
Massachusetts (1732)
Michigan (83)
Minnesota (103)
Mississippi (1)
Missouri (19)
Montana (9)
Nebraska (9)
Nevada (11)
New Hampshire (8)
New Jersey (608)
New Mexico (9)
New York (596)
North Carolina (366)
North Dakota (4)
Northern California (1019)
Ohio (70)
Oklahoma (7)
Oregon (6)
Pennsylvania (526)
Puerto Rico (3)
Rhode Island (5)
South America (367)
South Carolina (4)
Southern California (902)
Tennessee (19)
Texas (326)
Utah (35)
Virginia (64)
Washington D.C. (13)
Washington State (337)
West Virginia (3)
Wisconsin (8)
215,208 Results for "vir biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Leadership
Vir Leans Into Immunology Roots After Flamed-Out COVID Fame
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer stepped in as CEO to answer a critical question: What’s next?
February 12, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
March 13, 2025
·
9 min read
Press Releases
Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference
February 19, 2025
·
1 min read
Press Releases
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
·
20 min read
Press Releases
Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC
January 8, 2025
·
10 min read
Biotech Bay
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2024 Annual Meeting of Stockholders on Wednesday, May 29, 2024, at 9:00 a.m. PT.
May 23, 2024
·
1 min read
Press Releases
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
February 12, 2025
·
1 min read
Press Releases
Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
·
1 min read
Business
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
19 min read
FDA
Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application and granted Fast Track designatio.
June 26, 2024
·
7 min read
1 of 21,521
Next
